4//SEC Filing
Happel David 4
Accession 0001104659-23-120027
CIK 0001400118other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 9:59 PM ET
Size
5.0 KB
Accession
0001104659-23-120027
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Purchase
Series A Common Stock
2023-11-16$2.35/sh+590$1,387→ 590 total
Footnotes (1)
- [F1]Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.31 per share to $2.40 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each price.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001623567
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 9:59 PM ET
- Size
- 5.0 KB